Clasp Therapeutics
PrivateLast Round
Series A
Mar 20, 2024
Total Funding Raised
$150M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Clasp Therapeutics is a biotechnology company developing next-generation T cell engagers that target tumor-specific oncogenic driver mutations for hard-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clasp Therapeutics Comparables
Compare Clasp Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cytospire Therapeutics | 81% | |
| CDR-Life | 81% | |
| Adaptin Bio | 76% | |
Clasp Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 20, 2024 |
Key People
Founding team and executive leadership
Clasp Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalio Capital Management | Series A |
| BrightEdge | Series A |
| Johns Hopkins University Endowment | Series A |
| Novo Holdings | Series A |
| Pictet Alternative Advisors | Series A |
| Alexandria Venture Investments | Series A |
| Cure Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 58% MoM.
- Apr 28, 2025
Nonclinical data for CLSP-1025 presented at 2025 AACR Annual Meeting.
Clasp Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Clasp Therapeutics's valuation, stock price, and market status.